Cafepharma Today

January 23 2024 - AbbVie pulls off a hat trick with 3rd straight year as top TV drug ad spender
AbbVie pulls off a hat trick with 3rd straight year as top TV drug ad spender
FDA tacks boxed warning on Teva’s Copaxone, other MS drugs
RFK Jr. plans to keep a financial stake in lawsuits against the drugmaker Merck
Biogen research team hit by layoffs as company shifts resources to external opportunities
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Trump Administration Delays Funding To Cancer Research
Forbes
Thursday, January 23, 2025 - 11:13pm
tags:
Donald Trump, NIH, clinical trials, funding, cancer
AstraZeneca invests $570M to grow in Canada, plans to add 700 jobs
Fierce Biotech
Thursday, January 23, 2025 - 11:10pm
tags:
AstraZeneca, hirings, Canada
Here’s Why Beta Bionics Filing for an IPO Is a Big Deal
Medical Devices and Diagnostics Industry
Thursday, January 23, 2025 - 11:09pm
tags:
Medtech, Beta Bionics, IPOs, iLet Bionic Pancreas
Sacklers Up Their Offer to Settle Purdue Opioids Cases, With a New Condition
NY Times, NY
Thursday, January 23, 2025 - 11:07pm
tags:
Purdue Pharma, Sackler family, legal, opioids, opioid crisis
Masimo Snags a New CEO
Medical Devices and Diagnostics Industry
Thursday, January 23, 2025 - 11:05pm
tags:
Masimo, Medtech, Katie Szyman
Senate sets date to vet RFK Jr.’s nomination to lead HHS
BioPharma Dive
Thursday, January 23, 2025 - 11:04pm
tags:
Senate, HHS, Robert F Kennedy Jr.
AbbVie pulls off a hat trick with 3rd straight year as top TV drug ad spender, buoyed by Skyrizi and Rinvoq spots
Fierce Pharma
Thursday, January 23, 2025 - 12:00pm
tags:
AbbVie, TV ads, DTC advertising, Skyrizi, Rinvoq
AI in medtech is taking off. Here are 4 trends to watch in 2025.
BioPharma Dive
Thursday, January 23, 2025 - 11:50am
tags:
artificial intelligence, AI, Medtech, FDA, hospitals
Merck KGaA says high asset prices call for prudent M&A approach
MSN/Reuters
Thursday, January 23, 2025 - 11:48am
tags:
Merck KGaA, Belén Garijo, M&A
AbbVie Teams Up With Neomorph for Molecular Glue Collab Worth up to $1.64B
BioSpace
Thursday, January 23, 2025 - 11:47am
tags:
AbbVie, Neomorph, molecular glue, molecular glue degraders
Intellia doses first subject in trial of NTLA-2002 for hereditary angioedema
Clinical Trials Arena
Thursday, January 23, 2025 - 11:46am
tags:
Intellia Therapeutics, NTLA-2002, clinical trials, HAE, hereditary angiodema
FDA Tacks Boxed Warning on Teva’s Copaxone, Other MS Drugs
BioSpace
Thursday, January 23, 2025 - 11:44am
tags:
Teva Pharmaceutical, black box, MS, multiple sclerosis, FDA, anaphylaxis
Maternal RSV vaccines found to cut infection risk
Axios
Thursday, January 23, 2025 - 11:42am
tags:
RSV, vaccines, Pfizer, Abrysvo, infants
GSK, Merck and Pfizer in Ab&B’s sights as Chinese vaccine biotech files for IPO
Fierce Biotech
Thursday, January 23, 2025 - 11:40am
tags:
Ab&B Bio-Tech, GSK, Merck, Pfizer, China, vaccines, IPOs
US/EU regulators start review of Biogen's high-dose Spinraza
Pharmaphorum
Thursday, January 23, 2025 - 11:39am
tags:
Biogen, Spinraza, SMQA
Navigating FDA’s Draft Guidance for AI-Enabled Medical Devices
Medical Devices and Diagnostics Industry
Thursday, January 23, 2025 - 11:37am
tags:
Medtech, artificial intelligence, AI-enabled devices, FDA, regulatory
RFK Jr. plans to keep a financial stake in lawsuits against the drugmaker Merck
NPR
Thursday, January 23, 2025 - 11:35am
tags:
Robert F Kennedy Jr., HHS, legal, Merck, Gardasil, vaccines
Biogen research team hit by layoffs as company shifts resources to external opportunities
Fierce Biotech
Wednesday, January 22, 2025 - 7:29pm
tags:
Biogen, R&D, layoffs
BMS, Takeda's Chinese partners file for IPOs, sending Ascentage, Biokin and Bao bundling toward listings
Fierce Biotech
Wednesday, January 22, 2025 - 7:28pm
tags:
China, Takeda, Bristol Myers Squibb, IPOs, Ascentage Pharma, Sichuan Biokin Pharmaceutical, Shanghai Bao
Pulse Biosciences touts positive results from PFA early feasibility study
Clinical Trials Arena
Wednesday, January 22, 2025 - 7:26pm
tags:
Medtech, Pulse Biosciences, PFA, CellFX, atrial fibrillation

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels
2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline
Versatile Chaperones
In the Pipeline
Dealing With Being a Tumor Cell
In the Pipeline
Why 340B Reform Could Happen in 2025 (video)
Drug Channels

Latest Jobs

Onsite Endoscopic Specialist - Operating Room Support
Santa Monica, California
KARL STORZ Endoscopy - America
Area Manager, Immunology Rochester, NY Territory
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Tarrytown, NY
Tarrytown, New York
Lundbeck
Area Manager Specialty, West- Central
Fields, Oregon, 97710
CSL Behring
Area Sale Manager, Immunology Tampa North
Fields, Oregon, 97710
CSL Behring
Sales Representative
Boise, Idaho, 83708
Bartlett Roofing
Capital Project Manager
Carteret, New Jersey, United States
The Spear Group
Area Manager Specialty, West
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Midland, TX
Midland, Texas, 79701
Lundbeck
Home Health and Medical Sales
The Woodlands, Texas, 77381
Comfort Keepers of Dallas TX
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information